Jens Erik Nielsen-Kudsk
Latest contributions
LAA closure and pulmonary embolism hotline
22 May 2026 – From EuroPCR 2026
Focusing on left atrial appendage (LAA) closure and pulmonary embolism management, this session reviews device-related thrombus, implant healing with novel coatings, and compares mechanical thrombectomy to catheter-directed thrombolysis. It also discusses the prognostic impact of hemodynamic data post-thrombectomy to inform clinical outcomes.
Outcomes of LAA closure vs. DOAC in patients with atrial fibrillation across different age groups
21 May 2026 – From EuroPCR 2026
This major late-breaking trial from EuroPCR 2026 highlights new insights from the CHAMPION AF study, one of the largest randomised trials comparing left atrial appendage closure (LAAC) with direct oral anticoagulants (DOACs) in patients with atrial fibrillation. In this interview, Philippe Garot and Jens Erik Nielsen-Kudsk...
Seeing differently, treating better: advanced imaging shaping modern structural heart practice
20 May 2026 – From EuroPCR 2026
This session explores the transformative role of advanced imaging, particularly 3D intracardiac echocardiography (ICE), in modern structural heart interventions. It provides practical insights into implementation, highlighting how these tools can enhance workflow efficiency and procedural confidence across transcatheter edge-to-edge repair (TEER), left atrial appendage (LAA) closure,...
A critical appraisal of the recent evidence in the LAA closure field
20 May 2026 – From EuroPCR 2026
This session critically appraises recent evidence in the left atrial appendage (LAA) closure field, focusing on landmark trials such as CHAMPION-AF and CLOSURE AF. It discusses how these findings may influence patient selection and clinical practice, offering guidance on integrating new evidence into decision-making for stroke...
Major Late-Breaking Trials from EuroPCR 2026
20 May 2026 – From EuroPCR 2026
This session presents major late-breaking trials from EuroPCR 2026, reviewing contemporary evidence on coronary revascularization in TAVI patients, long-term outcomes of PCI versus CABG for left main disease, and comparative effectiveness of LAA closure versus NOAC in atrial fibrillation across age groups, with clinical practice implications.
How to become a CHAMPION in LAA closure
19 May 2026 – From EuroPCR 2026
This session reviews the latest CHAMPION AF trial data and its implications for left atrial appendage (LAA) closure in patients with atrial fibrillation.
It explores how emerging evidence may influence clinical practice and patient selection, and how LAA closure could evolve across different atrial fibrillation populations.
A recorded...
How to prevent and manage complex and complicated LAA closure cases?
19 May 2026 – From EuroPCR 2026
Designed to enhance procedural success in transcatheter left atrial appendage closure, this session addresses identification of complex anatomies, management of intraprocedural challenges, and strategies to prevent and handle complications, illustrated by practical case examples and expert evaluations.
Digital late breakers: will LAAC become standard practice for patients with AF?
15 Apr 2026
In this replay, P. Garot, M. Bergmann and J.E. Nielsen‑Kudsk review current indications for LAAC, insights from the CHAMPION‑AF trial and practical case learnings.
LAA closure is evolving: are you ready?
17 Nov 2025 – From PCR London Valves 2025
This session addresses the evolving landscape of left atrial appendage (LAA) closure in stroke prevention for atrial fibrillation patients. It reviews unmet clinical needs, evaluates the latest evidence and guideline recommendations, and identifies patient populations that benefit most from LAA closure, with discussions on balancing efficacy...
Mastering simple and complex LAA closure: a step-by-step case-based approach
16 Nov 2025 – From PCR London Valves 2025
This case-based session offers a comprehensive approach to mastering left atrial appendage (LAA) closure, emphasizing the critical role of imaging from pre-procedural planning through execution. It covers patient selection, procedural strategies from experienced operators, device selection tailored to anatomy, and nuanced decision-making during challenging device releases...
Optimal use of cardiac imaging to plan and guide transcatheter LAA closure
22 May 2025 – From EuroPCR 2025
Optimize left atrial appendage (LAA) closure outcomes through expert use of cardiac imaging. This session details the role of various imaging modalities in pre-procedural planning, intraprocedural guidance, and post-procedural assessment. Gain practical insights on transesophageal echocardiography, computed tomography, intracardiac echocardiography, and their integration to enhance procedural...
A central role for cardiac imaging in transcatheter LAA closure
22 May 2025 – From EuroPCR 2025
Discover the central role of cardiac imaging in transcatheter left atrial appendage (LAA) closure. This session covers sealing techniques, advances in cardiac tomography for assessing LAA wall thickness, fusion of 3D computational modeling with fluoroscopy guidance, device healing evaluation through early serial imaging, and complex cases...
LAA closure and anthrombotic therapies
21 May 2025 – From EuroPCR 2025
Explore contemporary evidence on left atrial appendage (LAA) closure and associated antithrombotic therapies. This session covers strategies for antithrombotic de-escalation, efficacy and safety in patients with anticoagulation contraindications, breakthrough stroke etiology, and anatomical considerations in high-risk atrial fibrillation patients undergoing ablation.
Broadening OPTIONs for LAA closure: innovations and outcomes
20 May 2025 – From EuroPCR 2025
Explore the latest insights into LAA closure from EuroPCR 2025. This session highlights results from the OPTION trial—the largest RCT comparing LAAC (with Watchman FLX) to DOAC therapy in AF patients undergoing ablation. The findings? Comparable stroke prevention at 3 years, with a 56 % reduction...
LAA closure - LIVE case
16 May 2024 – From EuroPCR 2024
A 78-year-old woman with hypertension, diabetes, obesity, and a history of pacemaker implantation in 2023, presented with retinal hemorrhage while on NACO for AF. Despite a CHA2DS2-VASC score of 5, anticoagulation was withdrawn. The operators implanted a Watchman device in the LAA via a venous right femoral...
Management of LAA closure complications
16 May 2024 – From EuroPCR 2024
This session explores the various complications that can arise during left atrial appendage (LAA) closure procedures, including pericardial effusion, device embolisation, and procedural strokes. Learn how to identify risk factors, prevent these complications, and effectively manage them through case-based discussions and expert guidance.
Unusual cases of PFO closure
15 May 2024 – From EuroPCR 2024
This session will feature selected EuroPCR 2024 Clinical Case submissions focused on unusual cases of patent foramen ovale (PFO) closure. Attendees will have the opportunity to explore challenging cases, such as unexplained hypoxemia in an elderly man post-lung cancer lobectomy, a case of persistent dyspnea and...
Percutaneous LAA closure 2.0
17 May 2023 – From EuroPCR 2023
In these slides, delve into advanced Percutaneous LAA Closure 2.0. Optimise procedure planning, grasp key post-procedural follow-up aspects, master essential tips for WatchmanFLX and Amulet device implantation, and much more.
PFO closure: safety, challenging anatomies and complications
17 May 2023 – From EuroPCR 2023
Disocover these cases to master PFO closure! Understand indications and patient selection, execute safe procedures, and navigate pitfalls with effective management strategies.
What are the indications for PFO closure in 2023?
17 May 2023 – From EuroPCR 2023
David Hildick-Smith and Jens Erik Nielsen-Kudsk take a joint look at the issues related to PFO closure and its indications.
In particular, they discuss whether the PFO should be restricted to patients under the age of 60, whether to limit the procedure to PFOs that are considered to be...
How should I make PFO closure a safe and effective procedure?
20 Jul 2022
Watch now P. Calvert, J. E. Nielsen-Kudsk and O. Muller for this PCR Webinars on PFO closure
State-of-the-art imaging for structural heart disease interventions
19 May 2022 – From EuroPCR 2022
This EuroPCR 2022 session aims to focus on imaging and help understand what imaging has changed in recent years: learn how to perform pre-procedural planning and how advanced imaging can make procedures easier and safer.
Looking at the heart and the brain - What is the role of LAA closure?
18 May 2022 – From EuroPCR 2022
Based on a pre-registered case study of a 68-year-old male patient, DG, who presented with atrial fibrillation, intracranial bleeding on warfarin, and compartment syndrome secondary to bleeding from warfarin, this EuroPCR 2022 session will allow you to discuss the challenges of treating AF patients with previous intracranial...
